HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN ENGLAND: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY

被引：0

作者：

Siddiqui, S. ^{[1
]}

Dolin, P. ^{[2
]}

Shavit, A. ^{[2
]}

Rowell, J. ^{[3
]}

Edmonds, C. ^{[4
]}

Kielar, D. ^{[2
]}

Persson, J. ^{[5
]}

Lacetera, A. ^{[6
]}

Suarez-Sanchez, P. ^{[6
]}

Ariti, C. ^{[6
]}

Podmore, B. ^{[6
]}

Velarde, A. Kitchin ^{[6
]}

Chen, S. Y. ^{[7
]}

机构：

[1] Imperial Coll London, Natl Heart & Lung Inst, NIHR Imperial Biomed Res Ctr, London, England

[2] AstraZeneca, BioPharmaceut Med, Cambridge, England

[3] AstraZeneca, Market Access & Pricing, Cambridge, England

[4] AstraZeneca, Market Access & Pricing, Gaithersburg, MD USA

[5] AstraZeneca, Market Access & Pricing, Gothenburg, Sweden

[6] OXONEpidemiology, Madrid, Spain

[7] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA

来源：

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE428

引用

页码：S139 / S140

页数：2